Related Experiment Video
Updated: May 7, 2026
11:39
The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
Published on: July 11, 2013
Psychotropic medications in dermatology
Daniel C Butler1, Josie Howard
1University of Arizona College of Medicine, Tucson, AZ, USA. Dcbutler@email.arizona.edu
Seminars in Cutaneous Medicine and Surgery
|September 21, 2013
Summary
Psychotropic medications are key for treating psychodermatologic conditions. Dermatologists can improve patient outcomes by understanding these drugs, especially when patients avoid psychiatric care.
Area of Science:
- Dermatology
- Psychiatry
- Pharmacology
Background:
- Psychodermatologic disorders require a multidisciplinary approach.
- Patients frequently decline psychiatric evaluations, necessitating dermatologists' involvement in psychotropic prescribing.
- Dermatologists face challenges managing both primary and secondary psychodermatologic conditions.
Purpose of the Study:
- To highlight the importance of psychotropic medications in psychodermatology.
- To equip dermatologists with the knowledge to prescribe psychotropic medications effectively.
- To address the management of primary and secondary psychodermatologic pathology.
Main Methods:
- Review of psychotropic medication indications and uses relevant to dermatology.
- Discussion of challenges faced by dermatologists in psychotropic prescribing.
- Emphasis on the role of dermatologists in managing psychodermatologic disorders.
Main Results:
- Psychotropic medications are integral to treating psychodermatologic disorders.
- Dermatologists are often the primary prescribers due to patient reluctance for psychiatric referral.
- Adequate knowledge enhances dermatologists' ability to manage these complex conditions.
Conclusions:
- Dermatologists need enhanced knowledge of psychotropic medications for effective patient care.
- Improving dermatologists' comfort with psychotropic prescribing can improve psychodermatologic treatment outcomes.
- Addressing psychodermatologic pathology requires dermatologists to be proficient in psychotropic medication management.
Related Concept Videos
01:28Drug Therapy
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
01:28Psychosis and Antipsychotic Drugs: Overview
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic symptoms in all...
01:26Psychosis: Goals of Pharmacotherapy
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation. For...
01:22CNS Stimulants: Psychedelic Agents
Hallucinogens, also known as psychedelic drugs, are a class of substances known for their ability to alter perception, cognition, and emotions. Despite their profound effects on the mind, these drugs are non-addictive, setting them apart from many other abused substances. The mechanism of action of these drugs lies in their impact on the 5-HT2A receptor in the brain. Upon activation, this receptor couples to Gq-type G proteins, triggering a cascade that releases intracellular calcium. This...
01:17Sedatives and Hypnotics Drugs: Miscellaneous Agents
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
01:23Antidepressant Drugs: MAOIs and Other Agents
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...